Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells

Cytotherapy

Volumn 5, Issue 1, 2003, Pages 87-98

  De Bruyn, Cecille ^a   Delforge, A ^a   Bernier, M ^a   Bron, D ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Cord blood; Ex vivo expansion; Myeloid differentiation

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; LACTOFERRIN; LATEX; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; STEM CELL FACTOR; THROMBOPOIETIN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; BLOOD SAMPLING; BLOOD TRANSFUSION; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GRANULE; CELL ISOLATION; CELL LINEAGE; CELL MANIPULATION; CELL MATURATION; CELL STRUCTURE; CELL TRANSPLANTATION; CRYOPRESERVATION; CULTURE MEDIUM; CYTOLOGY; EX VIVO STUDY; GRANULOCYTE; LEUKOCYTE; NEUTROPENIA; NEUTROPHIL; PHAGOCYTOSIS; PROMYELOCYTE; STAGING; STROMA CELL; THAWING; TYPES OF STUDY; UMBILICAL CORD BLOOD;

EID: 0037240226     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240310000119     Document Type: Article

References (45)

1. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
2. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000;28:1197-205.
3. McNiece I, Jones R, Cagnoni P et al. Ex-vivo expansion of hematopoietic progenitor cells: Preliminary results in breast cancer. Hematol Cell Ther 1999;41:82-6.
4. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995;333:283-7.
5. Williams SF, Lee WJ, Bender JG et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996;87:1687-91.
6. Alcorn MJ, Holyoake TL, Richmond L et al. CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 1996;14:1839-47.
7. Scheding S, Meister B, Buhring HJ et al. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells. Exp Hematol 2000;28:460-70.
8. McNiece I, Jones R, Bearman SI et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000;96:3001-7.
9. Zimmerman TM, Lee WJ, Bender JG et al. Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue. Bone Marrow Transplant 2000;26:505-10.
10. Fernandez MN, Granena A, Millan I et al. Evaluation of engraftment of ex vivo expanded cord blood cells in humans. Bone Marrow Transplant 2000;26(Suppl 2):S61-7.
11. Koller MR, Emerson SG, Palsson BO. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993;82:378-84.
12. Bagley J, Rosenzweig M, Marks DF, Pykett MJ. Extended culture of multipotent hematopoietic progenitors without cytokine augmentation in a novel three-dimensional device. Exp Hematol 1999;27:496-504.
13. Kohler T, Plettig R, Wetzstein W et al. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells 1999;17:19-24.
14. Mellado-Damas N, Rodriguez JM, Carmona M et al. Ex-vivo expansion and maturation of CD34-positive hematopoietic progenitors optimization of culture conditions. Leuk Res 1999;23:1035-40.
15. Shih CC, DiGiusto D, Forman SJ. Ex vivo expansion of transplantable human hematopoietic stem cells: Where do we stand in the year 2000? J Hematother Stem Cell Res 2000;9:621-8.
16. Brugger W, Scheding S, Ziegler B et al. Ex vivo manipulation of hematopoietic stem and progenitor cells. Semin Hematol 2000;37:42-9.
17. McNiece I, Briddell R. Ex vivo expansion of hematopoietic progenitor cells and mature cells. Exp Hematol 2001;29:3-11.
18. Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978;298:659-68.
19. Pryzwansky KB, Martin LE, Spitznagel JK. Immunocytochemical localization of myeloperoxidase, lactoferrin, lysozyme and neutral proteases in human monocytes and neutrophilic granulocytes. J Reticuloendothelial Soc 1978;24:295-310.
20. Oseas R, Yang HH, Baehner RL, Boxer LA. Lactoferrin: A promoter of polymorphonuclear leukocyte adhesiveness. Blood 1981;57:939-45.
21. Nieldez-Nguyen TM, Vetillard J, Drouet M et al. Functional studies of maturing myeloid cells during ex vivo expansion for treatment of aplasia: Feasibility of ex vivo expansion from cryopreserved bone marrow cell samples. J Hematother 1998;7:69-79.
22. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 1990;4:657-63.
23. Terstappen LW, Buescher S, Nguyen M, Reading C. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia 1992;6:1001-10.
24. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 1971;134:907-34.
25. Nagel JE, Han K, Coon PJ et al. Age differences in phagocytosis by polymorphonuclear leukocytes measured by flow cytometry. J Leukoc Biol 1986;39:399-407.
26. Haylock DN, To LB, Dowse TL et al. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992;80:1405-12.
27. + cells enriched from human bone marrow. Exp Hematol 1993;21:870-7.
28. Lill MC, Lynch M, Fraser JK et al. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system. Stem Cells 1994;12:626-37.
29. Scheding S, Kratz-Albers K, Meister B et al. Ex vivo expansion of hematopoietic progenitor cells for clinical use. Semin Hematol 1998;35:232-40.
30. + progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia. Stem Cells 1999;17:210-8.
31. + cells accelerate haematological recovery in a baboon model of autologous transplantation. Br J Haematol 2000;109:162-72.
32. Reiffers J, Cailliot C, Dazey B et al. Abrogation of postmyeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999;354:1092-3.
33. Paquette RL, Dergham ST, Karpf E et al. Ex vivo expanded unselected peripheral blood: Progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 2000;96:2385-90.
34. Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000;25:797-9.
35. Kogler G, Nurnberger W, Fischer J et al. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplant 1999;24:397-403.
36. Paquette RL, Gonzales E, Yoshimura R et al. Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free media. J Hematother 1998;7:481-91.
37. + hematopoietic progenitor cells. Blood 1995;86:4115-23.
38. + cells during ex vivo expansion using thrombopoietin, flt3-ligand and/or granulocyte-colony stimulating factor. Br J Haematol 1999;105:1034-40.
39. + cells from peripheral blood and bone marrow in serum-free culture medium with PIXY321 and granulocyte-colony stimulating factor (G-CSF). J Hematother 1997;6:323-34.
40. Leary AG, Zeng HQ, Clark SC, Ogawa M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci USA 1992;89:4013-7.
41. Yang YC, Clark SC. Human interleukin 3: Analysis of the gene and its role in the regulation of hematopoiesis. Int J Cell Cloning 1990;8(Suppl 1):121-8.
42. Verfaillie CM, Catanzaro PM, Li WN. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 1994;179:643-9.
43. Torok-Storb B, Iwata M, Graf L et al. Dissecting the marrow microenvironment. Ann N Y Acad Sci 1999;872:164-70.
44. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1992;49:225-33.
45. Liesveld JL, Harbol AW, Belanger T et al. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: Effects of progenitor isolation method and cell-cell contact. Blood Cells Mol Dis 2000;26:261-75.